Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection
P Ghiara(Angiologica (Italy)), Giuseppe Del Giudice(University of Naples Federico II), A. Di Tommaso, A Covacci(Angiologica (Italy)), Carla Vindigni(National Institutes of Health), John L. Telford(Angiologica (Italy)), Michela Rossi, Rino Rappuoli(University of Siena), Marta Marchetti(Humanitas University), F Ciampolini, Maria Teresa De Magistris, Mariagrazia Pizza(Imperial College London)
Cited by 182
Related Papers
<i>cag</i> , a pathogenicity island of <i>Helicobacter pylori,</i> encodes type I-specific and disease-associated virulence factors
|Proceedings of the National Academy of Sciences|1996|1.9k
Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.
|The Journal of Experimental Medicine|1994|591
Development of a Mouse Model of <i>Helicobacter pylori</i> Infection that Mimics Human Disease
|Science|1995|568
Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity
|Infection and Immunity|1996|432
<i>Helicobacter pylori</i> -Induced Mucosal Inflammation Is Th1 Mediated and Exacerbated in IL-4, But Not IFN-γ, Gene-Deficient Mice
|The Journal of Immunology|2000|338